Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
106.00    4.00 (3.92%)
Bid:
103.80
Ask:
105.20
Spread: 1.40 (1.349%)
Market Cap: £644.68m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Director/PDMR Shareholding

27 Mar 2019 11:12

RNS Number : 1827U
Syncona Limited
27 March 2019
 

Syncona Limited

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons

 

27 March 2019

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Nicholas Moss

b)

Position / status

Senior Independent Director

c)

Initial notification / amendment

Initial Notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares

GG00B8P59C08

 

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.497

8,004

d)

Aggregated information

Aggregated volume

Price

 N/A

e)

Date of the transaction

22 March 2019

f)

Place of the transaction

London Stock Exchange

g)

Currency

GBP - British Pound

 

 

[ENDS]

 

Enquiries

Syncona Ltd

Annabel Clay

Tel: +44 (0) 20 7611 2031

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBRARKKAOUAR
Date   Source Headline
18th May 20217:00 amRNSNotice of Results
18th May 20217:00 amRNSFreeline reports Q1 results
12th May 20213:05 pmRNSAutolus to present additional data in AUTO1
12th May 20211:18 pmRNSDirector/PDMR Shareholding
11th May 202112:05 pmRNSAchilles reports Q1 financial results
7th May 20217:00 amRNSGyroscope Therapeutics update on proposed IPO
6th May 202112:05 pmRNSAutolus reports Q1 2021 Financial Results
4th May 20217:00 amRNSUpdate on Gyroscope proposed IPO in the US
19th Apr 202112:05 pmRNSAutolus appoints non-executive Chair
19th Apr 20217:00 amRNSGyroscope files registration statement
6th Apr 20214:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSFreeline Reports Financial Results
31st Mar 20217:00 amRNSAchilles update on IPO
30th Mar 202112:04 pmRNSDirector/PDMR Shareholding
26th Mar 20217:06 amRNSGyroscope announces additional financing plans
26th Mar 20217:00 amRNSSyncona cornerstones $148m Series C in Gyroscope
25th Mar 202111:13 amRNSUpdate on Achilles’ proposed IPO
4th Mar 202112:10 pmRNSAutolus Reports Full Year 2020 Financial Results
2nd Mar 20217:00 amRNSAchilles files registration statement
12th Feb 20213:49 pmRNSGyroscope Announces Positive Interim Data
11th Feb 20217:00 amRNSNew commitment to Quell in largest ever Series A
11th Feb 20217:00 amRNSQuarterly and Business Update
10th Feb 20217:00 amRNSAutolus announces pricing of public offering
8th Feb 202112:09 pmRNSFreeline Updates Clinical Development Plan
5th Feb 20217:00 amRNSAchilles announces additional financing plans
5th Feb 20217:00 amRNSAchilles data and safety committee review
6th Jan 20217:00 amRNSAutolus Business Outlook
21st Dec 20207:00 amRNSVirginia Holmes Appointed Non-Executive Director
14th Dec 202012:05 pmRNSFreeline reports updated clinical data
7th Dec 20205:05 pmRNSAutolus presents additional data on AUTO3
7th Dec 20207:05 amRNSAutolus presents additional data on AUTO1
27th Nov 20204:35 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSSyncona founds Purespring with a £45m Series A
19th Nov 20207:00 amRNSHalf-year Report
5th Nov 202012:11 pmRNSAutolus reports Q3 2020 Financial Results
3rd Nov 20208:30 amRNSNotice of Results
2nd Nov 20207:00 amRNSDirectorate Change
30th Oct 20207:00 amRNSFreeline H1 Results and Business Highlights
18th Sep 20208:10 amRNSAutolus presents additional data on AUTO3
14th Sep 20201:05 pmRNSSyncona expands cell therapy portfolio
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSQuarterly Update
7th Aug 20207:00 amRNSFreeline update on IPO
6th Aug 202012:10 pmRNSAutolus reports Q2 2020 Financial Results
3rd Aug 202011:30 amRNSUpdate on Freeline proposed IPO in the U.S.
28th Jul 202012:00 pmRNSResult of AGM
20th Jul 20207:00 amRNSFreeline files registration statement
13th Jul 20204:51 pmRNSFreeline publishes further data for FLT180a
9th Jul 20201:00 pmRNSIssue of shares pursuant to Incentive Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.